drugset / Trial / NCT02111330

Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF -509 (80 mg, 160 mg and 240 mg) "After Multiple Oral Doses" in Healthy Volunteers

NCT02111330 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

Study to assess the safety and tolerability of three doses of PBF-509 (80 mg, 160 mg and 240 mg) after repeated (8 days) single daily oral dose administration in young male and female healthy subjects.

Timeline

Start
2014-03
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject PBF-509 Unknown 80 mg Oral
Subject PBF-509 Unknown 160 mg Oral
Subject PBF-509 Unknown 240 mg Oral

Indications